These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 29429782)

  • 41. Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann-Pick Disease Type C Model Mice.
    Fukaura M; Ishitsuka Y; Shirakawa S; Ushihama N; Yamada Y; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Kurauchi Y; Seki T; Katsuki H; Higaki K; Matsuo M; Irie T
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Niemann-Pick type C: a potentially treatable disorder?
    Kheder A; Scott C; Olpin S; Hadjivassiliou M
    Pract Neurol; 2013 Dec; 13(6):382-5. PubMed ID: 23906593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenotype assessment for neurodegenerative murine models with ataxia and application to Niemann-Pick disease, type C1.
    Yerger J; Cougnoux AC; Abbott CB; Luke R; Clark TS; Cawley NX; Porter FD; Davidson CD
    Biol Open; 2022 Apr; 11(4):. PubMed ID: 35452076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased neural stem cell proliferation and olfaction in mouse models of Niemann-Pick C1 disease and the response to hydroxypropyl-β-cyclodextrin.
    Dragotto J; Palladino G; Canterini S; Caporali P; Patil R; Fiorenza MT; Erickson RP
    J Appl Genet; 2019 Nov; 60(3-4):357-365. PubMed ID: 31485950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lactose-Appended Hydroxypropyl-β-Cyclodextrin Lowers Cholesterol Accumulation and Alleviates Motor Dysfunction in Niemann-Pick Type C Disease Model Mice.
    Nishida T; Yokoyama R; Kubohira Y; Maeda Y; Takeo T; Nakagata N; Takagi H; Ishikura K; Yanagihara K; Misumi S; Kishimoto N; Ishitsuka Y; Kondo Y; Irie T; Soga M; Era T; Onodera R; Higashi T; Motoyama K
    ACS Appl Bio Mater; 2022 May; 5(5):2377-2388. PubMed ID: 35506864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
    Cuisset JM; Sukno S; Trauffler A; Latour P; Dobbelaere D; Michaud L; Vallée L
    J Med Case Rep; 2016 Sep; 10(1):241. PubMed ID: 27599728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclodextrin triggers MCOLN1-dependent endo-lysosome secretion in Niemann-Pick type C cells.
    Vacca F; Vossio S; Mercier V; Moreau D; Johnson S; Scott CC; Montoya JP; Moniatte M; Gruenberg J
    J Lipid Res; 2019 Apr; 60(4):832-843. PubMed ID: 30709900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracerebroventricular 2-hydroxypropyl-γ-cyclodextrin alleviates hepatic manifestations without distributing to the liver in a murine model of Niemann-Pick disease type C.
    Yamada Y; Ishitsuka Y; Fukaura-Nishizawa M; Kawata T; Ishii A; Shirakawa A; Sakai T; Tanaka M; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Seki T; Kurauchi Y; Katsuki H; Higaki K; Ikeda R; Matsuo M; Era T; Irie T
    Life Sci; 2024 Aug; 350():122776. PubMed ID: 38852794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accumulation of alkyl-lysophosphatidylcholines in Niemann-Pick disease type C1.
    Mishra S; Kell P; Scherrer D; Dietzen DJ; Vite CH; Berry-Kravis E; Davidson C; Cologna SM; Porter FD; Ory DS; Jiang X
    J Lipid Res; 2024 Aug; 65(8):100600. PubMed ID: 39048052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 2-Hydroxypropyl-β-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease.
    Davidson J; Molitor E; Moores S; Gale SE; Subramanian K; Jiang X; Sidhu R; Kell P; Zhang J; Fujiwara H; Davidson C; Helquist P; Melancon BJ; Grigalunas M; Liu G; Salahi F; Wiest O; Xu X; Porter FD; Pipalia NH; Cruz DL; Holson EB; Schaffer JE; Walkley SU; Maxfield FR; Ory DS
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1545-1561. PubMed ID: 31051283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics and distribution of 2-hydroxypropyl-β-cyclodextrin following a single intrathecal dose to cats.
    Kao ML; Stellar S; Solon E; Lordi A; Kasica N; Swain G; Bagel JH; Gurda BL; Vite CH
    J Inherit Metab Dis; 2020 May; 43(3):618-634. PubMed ID: 31707730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of 2-Hydroxypropyl-β-cyclodextrin in Niemann-Pick Disease Type C Model Mice and Its Pharmacokinetic Analysis in a Patient with the Disease.
    Tanaka Y; Yamada Y; Ishitsuka Y; Matsuo M; Shiraishi K; Wada K; Uchio Y; Kondo Y; Takeo T; Nakagata N; Higashi T; Motoyama K; Arima H; Mochinaga S; Higaki K; Ohno K; Irie T
    Biol Pharm Bull; 2015; 38(6):844-51. PubMed ID: 26027824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The natural history of cerebellar degeneration of Niemann-Pick C mice monitored in vitro.
    Marschalek N; Albert F; Meske V; Ohm TG
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):933-45. PubMed ID: 24889722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of intracerebroventricular administration of 2-hydroxypropyl-β-cyclodextrin in a patient with Niemann-Pick Type C disease.
    Matsuo M; Shraishi K; Wada K; Ishitsuka Y; Doi H; Maeda M; Mizoguchi T; Eto J; Mochinaga S; Arima H; Irie T
    Mol Genet Metab Rep; 2014; 1():391-400. PubMed ID: 27896112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pilot study of direct delivery of hydroxypropyl-beta-cyclodextrin to the lung by the nasal route in a mouse model of Niemann-Pick C1 disease: motor performance is unaltered and lung disease is worsened.
    Erickson RP; Deutsch G; Patil R
    J Appl Genet; 2018 May; 59(2):187-191. PubMed ID: 29411332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Adult onset Niemann-Pick type C disease and psychosis: literature review].
    Maubert A; Hanon C; Metton JP
    Encephale; 2013 Oct; 39(5):315-9. PubMed ID: 23928063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann-Pick disease type C treatment.
    Yamada Y; Fukaura-Nishizawa M; Nishiyama A; Ishii A; Kawata T; Shirakawa A; Tanaka M; Kondo Y; Takeo T; Nakagata N; Miwa T; Takeda H; Orita Y; Motoyama K; Higashi T; Arima H; Seki T; Kurauchi Y; Katsuki H; Higaki K; Minami K; Yoshikawa N; Ikeda R; Matsuo M; Irie T; Ishitsuka Y
    Clin Transl Med; 2023 Aug; 13(8):e1350. PubMed ID: 37620691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In Niemann-Pick C1 mouse models, glial-only expression of the normal gene extends survival much further than do changes in genetic background or treatment with hydroxypropyl-beta-cyclodextrin.
    Marshall CA; Watkins-Chow DE; Palladino G; Deutsch G; Chandran K; Pavan WJ; Erickson RP
    Gene; 2018 Feb; 643():117-123. PubMed ID: 29223359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intrathecal cyclodextrin in the treatment of Niemann-Pick disease type C.
    Roch Santed M; Cabañas Poy MJ; Del Toro Riera M; Cañete Ramírez C; Fernández Polo A; Clemente Bautista S
    Eur J Hosp Pharm; 2017 May; 24(3):185-188. PubMed ID: 31156935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Miglustat in Niemann-Pick disease type C patients: a review.
    Pineda M; Walterfang M; Patterson MC
    Orphanet J Rare Dis; 2018 Aug; 13(1):140. PubMed ID: 30111334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.